David Heinzmann

University Children's Hospital Tübingen

Papers

1

Total Citations

6

H-Index

1

About

David Heinzmann is a biomedical engineer whose research focuses on the biophysical mechanisms of cardiac ablation, particularly the use of nanosecond pulsed electric fields (nsPEFs) for treating arrhythmias. His major contribution lies in demonstrating that fractionating nsPEFs—delivering them as shorter, spaced bursts—can significantly lower the lethal voltage threshold by enhancing cardiomyocyte membrane permeability. This finding, published in 2025 and already garnering 6 citations, addresses a critical challenge in pulsed field ablation: reducing the thermal damage caused by high-voltage, high-frequency pulses. By showing that fractionation reduces the required dose, Heinzmann’s work paves the way for safer, more effective clinical protocols. His research bridges fundamental cell biophysics with practical therapeutic design, offering a pathway to minimize collateral tissue heating while maintaining ablation efficacy. This achievement is particularly notable given the early stage of nsPEF clinical trials, positioning Heinzmann as a rising voice in the optimization of non-thermal cardiac interventions.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Fractionation of nanosecond pulsed electric fields lowers lethal dose by enhancing cardiomyocyte membrane permeability
6 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: University Children's Hospital Tübingen

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago